Diluted blood reperfusion as a model for transplantation of ischemic rat livers: Alanine aminotransferase is a direct indicator of viability

K. Uygun, H. Tolboom, M. L. Izamis, B. Uygun, N. Sharma, Hiroshi Yagi, A. Soto-Gutierrez, M. Hertl, F. Berthiaume, M. L. Yarmush

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Donors after cardiac death present a significant pool of untapped organs for transplantation, and use of machine perfusion strategies has been an active focus area in experimental transplantation. However, despite 2 decades of research, a gold standard has yet to emerge for machine perfusion systems and protocols. Whole blood reperfusion has been used as a surrogate for organ transplantation, especially as a model for the short-term response posttransplantation, and for optimization of perfusion systems. Although it is known that there is a strong correlation between liver function in whole-blood reperfusion and survival, the exact nature of these correlations, and to what extent they can be considered as an indicator of viability for transplantation/recipient survival, remain unclear. In this work, we demonstrate that diluted whole-blood reperfusion can be used as a direct model for transplantation of ischemic rat liver grafts. Specifically, we show that recipient survival can be predicted based simply on the value of alanine aminotransferase during perfusion, providing quantitative criteria of viability for use in this animal model. These results indicate that in the rat model graft survival is highly correlated with hepatocellular damage.

Original languageEnglish
Pages (from-to)2463-2467
Number of pages5
JournalTransplantation Proceedings
Volume42
Issue number7
DOIs
Publication statusPublished - 2010 Sep
Externally publishedYes

Fingerprint

Alanine Transaminase
Reperfusion
Perfusion
Transplantation
Liver
Organ Transplantation
Graft Survival
Animal Models
Transplants
Research

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Diluted blood reperfusion as a model for transplantation of ischemic rat livers : Alanine aminotransferase is a direct indicator of viability. / Uygun, K.; Tolboom, H.; Izamis, M. L.; Uygun, B.; Sharma, N.; Yagi, Hiroshi; Soto-Gutierrez, A.; Hertl, M.; Berthiaume, F.; Yarmush, M. L.

In: Transplantation Proceedings, Vol. 42, No. 7, 09.2010, p. 2463-2467.

Research output: Contribution to journalArticle

Uygun, K, Tolboom, H, Izamis, ML, Uygun, B, Sharma, N, Yagi, H, Soto-Gutierrez, A, Hertl, M, Berthiaume, F & Yarmush, ML 2010, 'Diluted blood reperfusion as a model for transplantation of ischemic rat livers: Alanine aminotransferase is a direct indicator of viability', Transplantation Proceedings, vol. 42, no. 7, pp. 2463-2467. https://doi.org/10.1016/j.transproceed.2010.04.037
Uygun, K. ; Tolboom, H. ; Izamis, M. L. ; Uygun, B. ; Sharma, N. ; Yagi, Hiroshi ; Soto-Gutierrez, A. ; Hertl, M. ; Berthiaume, F. ; Yarmush, M. L. / Diluted blood reperfusion as a model for transplantation of ischemic rat livers : Alanine aminotransferase is a direct indicator of viability. In: Transplantation Proceedings. 2010 ; Vol. 42, No. 7. pp. 2463-2467.
@article{c679b2f0a1af4e779414402bf792fb22,
title = "Diluted blood reperfusion as a model for transplantation of ischemic rat livers: Alanine aminotransferase is a direct indicator of viability",
abstract = "Donors after cardiac death present a significant pool of untapped organs for transplantation, and use of machine perfusion strategies has been an active focus area in experimental transplantation. However, despite 2 decades of research, a gold standard has yet to emerge for machine perfusion systems and protocols. Whole blood reperfusion has been used as a surrogate for organ transplantation, especially as a model for the short-term response posttransplantation, and for optimization of perfusion systems. Although it is known that there is a strong correlation between liver function in whole-blood reperfusion and survival, the exact nature of these correlations, and to what extent they can be considered as an indicator of viability for transplantation/recipient survival, remain unclear. In this work, we demonstrate that diluted whole-blood reperfusion can be used as a direct model for transplantation of ischemic rat liver grafts. Specifically, we show that recipient survival can be predicted based simply on the value of alanine aminotransferase during perfusion, providing quantitative criteria of viability for use in this animal model. These results indicate that in the rat model graft survival is highly correlated with hepatocellular damage.",
author = "K. Uygun and H. Tolboom and Izamis, {M. L.} and B. Uygun and N. Sharma and Hiroshi Yagi and A. Soto-Gutierrez and M. Hertl and F. Berthiaume and Yarmush, {M. L.}",
year = "2010",
month = "9",
doi = "10.1016/j.transproceed.2010.04.037",
language = "English",
volume = "42",
pages = "2463--2467",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Diluted blood reperfusion as a model for transplantation of ischemic rat livers

T2 - Alanine aminotransferase is a direct indicator of viability

AU - Uygun, K.

AU - Tolboom, H.

AU - Izamis, M. L.

AU - Uygun, B.

AU - Sharma, N.

AU - Yagi, Hiroshi

AU - Soto-Gutierrez, A.

AU - Hertl, M.

AU - Berthiaume, F.

AU - Yarmush, M. L.

PY - 2010/9

Y1 - 2010/9

N2 - Donors after cardiac death present a significant pool of untapped organs for transplantation, and use of machine perfusion strategies has been an active focus area in experimental transplantation. However, despite 2 decades of research, a gold standard has yet to emerge for machine perfusion systems and protocols. Whole blood reperfusion has been used as a surrogate for organ transplantation, especially as a model for the short-term response posttransplantation, and for optimization of perfusion systems. Although it is known that there is a strong correlation between liver function in whole-blood reperfusion and survival, the exact nature of these correlations, and to what extent they can be considered as an indicator of viability for transplantation/recipient survival, remain unclear. In this work, we demonstrate that diluted whole-blood reperfusion can be used as a direct model for transplantation of ischemic rat liver grafts. Specifically, we show that recipient survival can be predicted based simply on the value of alanine aminotransferase during perfusion, providing quantitative criteria of viability for use in this animal model. These results indicate that in the rat model graft survival is highly correlated with hepatocellular damage.

AB - Donors after cardiac death present a significant pool of untapped organs for transplantation, and use of machine perfusion strategies has been an active focus area in experimental transplantation. However, despite 2 decades of research, a gold standard has yet to emerge for machine perfusion systems and protocols. Whole blood reperfusion has been used as a surrogate for organ transplantation, especially as a model for the short-term response posttransplantation, and for optimization of perfusion systems. Although it is known that there is a strong correlation between liver function in whole-blood reperfusion and survival, the exact nature of these correlations, and to what extent they can be considered as an indicator of viability for transplantation/recipient survival, remain unclear. In this work, we demonstrate that diluted whole-blood reperfusion can be used as a direct model for transplantation of ischemic rat liver grafts. Specifically, we show that recipient survival can be predicted based simply on the value of alanine aminotransferase during perfusion, providing quantitative criteria of viability for use in this animal model. These results indicate that in the rat model graft survival is highly correlated with hepatocellular damage.

UR - http://www.scopus.com/inward/record.url?scp=77956457930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956457930&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2010.04.037

DO - 10.1016/j.transproceed.2010.04.037

M3 - Article

C2 - 20832525

AN - SCOPUS:77956457930

VL - 42

SP - 2463

EP - 2467

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 7

ER -